TopiVert is a private, clinical-stage biotechnology company developing next-generation, Narrow Spectrum Kinase Inhibitors as novel, topical, non-systemic medicines for the treatment of chronic inflammatory diseases of the gastrointestinal tract and the eye.
Total raised: $27.895101M
Founded date: 2011
Investors 1
| Date | Name | Website |
| - | NeoMed Man... | neomed.net... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 06.01.2014 | - | $27.895101... | NeoMed Man... | neomed.net... |
Mentions in press and media 1
| Date | Title | Description | Category | Author | Source |
| 06.01.2014 | NeoMed inv... | TopiVert Limited, a drug disco... | - | - | neomed.net... |